Proceedings of the National Academy of Sciences · 1996 · 106 citations · 47 references
Life SciencesCell BiologyHematologyCell SignalingCellular EngineeringStem Cell BiologyAnimal Cell CultureBlood Cell DifferentiationDevelopmental Biology ModelsHematopoietic DifferentiationHematopoietic Stem Cell BiologyCell Surface ProteinsFluorescent StainingGlycosylphosphatidylinositol AnchorsHuman Embryonic Stem CellsMouse Embryonic Stem CellsTargeted Gene DisruptionTherapeutic Gene Transfer
We created a "knockout" embryonic stem cell via targeted disruption of the phosphatidylinositol glycan class A (Pig-a) gene, resulting in loss of expression of cell surface glycosyl phosphatidylinositol-anchored proteins and reproducing the mutant phenotype of the human disease paroxysmal nocturnal hemoglobinuria. Morphogenesis of Pig-a- embryoid bodies (EB) in vitro was grossly aberrant and, unlike EB derived from normal embryonic stem cells, Pig-A EB produced no secondary hematopoietic colonies. Chimeric EB composed of control plus Pig-A- cells, however, appeared normal, and hematopoiesis from knock-out cells was reconstituted. Transfer in situ of glycosyl phosphatidylinositol-anchored proteins from normal to knock-out cells was demonstrated by two-color fluorescent analysis, suggesting a possible mechanism for these functional effects. Hematopoietic cells with mutated PIG-A genes in humans with paroxysmal nocturnal hemoglobinuria may be subject to comparable pathophysiologic processes and amenable to similar therapeutic protein transfer.
47
Natural History of Paroxysmal Nocturnal Hemoglobinuria
Peter Hillmen, S. M. Lewis, Monica Bessler et al. · New England Journal of Medicine · 1995 · 901 citations · Full text
Vasculogenesis and angiogenesis in embryonic-stem-cell-derived embryoid bodies
Werner Risau, Hannu Sariola, Hans‐Günter Zerwes et al. · Development · 1988 · 661 citations